Enveric Biosciences Inc
(ENVB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 1,898 | 2,477 | 2,384 | 3,448 | 5,755 |
| Operating Income | -1,898 | -2,477 | -2,384 | -3,448 | -5,755 |
| Interest Expense | 0 | 0 | 0 | -2 | -1 |
| Other Income | 19 | 22 | -1,029 | 631 | -602 |
| Pre-tax Income | -1,879 | -2,455 | -3,414 | -2,816 | -6,356 |
| Income Tax | N/A | 2 | 36 | -7 | N/A |
| Net Income Continuous | -1,879 | -2,457 | -3,449 | -2,809 | -6,356 |
| Net Income | $-1,879 | $-2,457 | $-3,436 | $-2,822 | $-6,356 |
| EPS Basic Total Ops | -44.66 | -110.56 | -259.18 | -233.98 | -547.15 |
| EPS Basic Continuous Ops | -44.59 | -110.57 | -260.21 | -233.52 | -542.68 |
| EPS Diluted Total Ops | -44.66 | -110.56 | -259.18 | -233.98 | -547.15 |
| EPS Diluted Continuous Ops | -44.59 | -110.57 | -260.21 | -233.52 | -542.68 |
| EPS Diluted Before Non-Recurring Items | -45.00 | -109.79 | -262.77 | N/A | N/A |
| EBITDA(a) | $-1,813 | $-2,392 | $-2,300 | $-3,353 | $-5,641 |